My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 136

    1.

    The second activating glucokinase mutation (A456V): implications for glucose homeostasis and diabetes therapy.

    Christesen HB, Jacobsen BB, Odili S, Buettger C, Cuesta-Munoz A, Hansen T, Brusgaard K, Massa O, Magnuson MA, Shiota C, Matschinsky FM, Barbetti F.

    Diabetes. 2002 Apr;51(4):1240-6.PMID: 11916951 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis.

    Davis EA, Cuesta-Muñoz A, Raoul M, Buettger C, Sweet I, Moates M, Magnuson MA, Matschinsky FM.

    Diabetologia. 1999 Oct;42(10):1175-86.PMID: 10525657 [PubMed - indexed for MEDLINE]Related articles

    3.

    Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.

    Cuesta-Muñoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Näntö-Salonen K, Rahier J, López-Enriquez S, García-Gimeno MA, Sanz P, Soriguer FC, Laakso M.

    Diabetes. 2004 Aug;53(8):2164-8.PMID: 15277402 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy.

    Wabitsch M, Lahr G, Van de Bunt M, Marchant C, Lindner M, von Puttkamer J, Fenneberg A, Debatin KM, Klein R, Ellard S, Clark A, Gloyn AL.

    Diabet Med. 2007 Dec;24(12):1393-9. Epub 2007 Nov 1.PMID: 17976205 [PubMed - indexed for MEDLINE]Related articles

    5.

    Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations.

    Sayed S, Langdon DR, Odili S, Chen P, Buettger C, Schiffman AB, Suchi M, Taub R, Grimsby J, Matschinsky FM, Stanley CA.

    Diabetes. 2009 Jun;58(6):1419-27. Epub 2009 Mar 31.PMID: 19336674 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.

    Gloyn AL, Noordam K, Willemsen MA, Ellard S, Lam WW, Campbell IW, Midgley P, Shiota C, Buettger C, Magnuson MA, Matschinsky FM, Hattersley AT.

    Diabetes. 2003 Sep;52(9):2433-40.PMID: 12941786 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).

    Burke CV, Buettger CW, Davis EA, McClane SJ, Matschinsky FM, Raper SE.

    Biochem J. 1999 Sep 1;342 ( Pt 2):345-52.PMID: 10455021 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Permanent neonatal diabetes caused by a homozygous nonsense mutation in the glucokinase gene.

    Rubio-Cabezas O, Díaz González F, Aragonés A, Argente J, Campos-Barros A.

    Pediatr Diabetes. 2008 Jun;9(3 Pt 1):245-9. Epub 2008 Feb 21.PMID: 18298419 [PubMed - indexed for MEDLINE]Related articles

    9.

    Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations.

    Heredia VV, Carlson TJ, Garcia E, Sun S.

    J Biol Chem. 2006 Dec 29;281(52):40201-7. Epub 2006 Nov 2.PMID: 17082186 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations.

    Pino MF, Kim KA, Shelton KD, Lindner J, Odili S, Li C, Collins HW, Shiota M, Matschinsky FM, Magnuson MA.

    J Biol Chem. 2007 May 4;282(18):13906-16. Epub 2007 Mar 12.PMID: 17353190 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway.

    Njølstad PR, Sagen JV, Bjørkhaug L, Odili S, Shehadeh N, Bakry D, Sarici SU, Alpay F, Molnes J, Molven A, Søvik O, Matschinsky FM.

    Diabetes. 2003 Nov;52(11):2854-60.PMID: 14578306 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics.

    Matschinsky FM.

    Diabetes. 2002 Dec;51 Suppl 3:S394-404. Review.PMID: 12475782 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Diagnostic difficulties in glucokinase hyperinsulinism.

    Meissner T, Marquard J, Cobo-Vuilleumier N, Maringa M, Rodríguez-Bada P, García-Gimeno MA, Baixeras E, Weber J, Olek K, Sanz P, Mayatepek E, Cuesta-Muñoz AL.

    Horm Metab Res. 2009 Apr;41(4):320-6. Epub 2008 Dec 3.PMID: 19053014 [PubMed - indexed for MEDLINE]Related articles

    14.

    Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.

    Christesen HB, Brusgaard K, Beck Nielsen H, Brock Jacobsen B.

    Clin Endocrinol (Oxf). 2008 May;68(5):747-55. Epub 2008 Jan 15. Erratum in: Clin Endocrinol (Oxf). 2008 Jun;68(6):1011. PMID: 18208578 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young.

    Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HA, Steele AM, Stride A, Shiota C, Magnuson MA, Lorini R, d'Annunzio G, Stanley CA, Kwagh J, van Schaftingen E, Veiga-da-Cunha M, Barbetti F, Dunten P, Han Y, Grimsby J, Taub R, Ellard S, Hattersley AT, Matschinsky FM.

    J Biol Chem. 2005 Apr 8;280(14):14105-13. Epub 2005 Jan 25.PMID: 15677479 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Glucokinase mutations, insulin secretion, and diabetes mellitus.

    Bell GI, Pilkis SJ, Weber IT, Polonsky KS.

    Annu Rev Physiol. 1996;58:171-86. Review.PMID: 8815790 [PubMed - indexed for MEDLINE]Related articles

    17.

    A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria.

    Ellard S, Beards F, Allen LI, Shepherd M, Ballantyne E, Harvey R, Hattersley AT.

    Diabetologia. 2000 Feb;43(2):250-3.PMID: 10753050 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

    Gloyn AL.

    Hum Mutat. 2003 Nov;22(5):353-62. Review.PMID: 14517946 [PubMed - indexed for MEDLINE]Related articles

    19.

    Allosteric activators of glucokinase: potential role in diabetes therapy.

    Grimsby J, Sarabu R, Corbett WL, Haynes NE, Bizzarro FT, Coffey JW, Guertin KR, Hilliard DW, Kester RF, Mahaney PE, Marcus L, Qi L, Spence CL, Tengi J, Magnuson MA, Chu CA, Dvorozniak MT, Matschinsky FM, Grippo JF.

    Science. 2003 Jul 18;301(5631):370-3.PMID: 12869762 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.

    Retnakaran R, Hanley AJ, Sermer M, Zinman B.

    Diabetes Care. 2005 Nov;28(11):2710-5.PMID: 16249544 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity